The ubiquitin-proteasome pathway in cancer

被引:191
作者
Spataro, V [1 ]
Norbury, C [1 ]
Harris, AL [1 ]
机构
[1] Univ Oxford, Inst Mol Med, Imperial Canc Res Fund, Mol Oncol Lab, Oxford OX3 9DS, England
关键词
ubiquitin; proteasome; oncogenesis; drug resistance; immune escape;
D O I
10.1038/bjc.1998.71
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Degradation by the 26S proteasome of specific proteins that have been targeted by the ubiquitin pathway is the major intracellular non-lysosomal proteolytic mechanism and is involved in a broad range of processes, such as cell cycle progression, antigen presentation and control of gene expression. Recent work, reviewed here, has shown that this pathway is often the target of cancer-related deregulation and can underlie processes, such as oncogenic transformation, tumour progression, escape from immune surveillance and drug resistance.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 101 条
[1]   CLOSING THE CELL-CYCLE CIRCLE IN YEAST - G2 CYCLIN PROTEOLYSIS INITIATED AT MITOSIS PERSISTS UNTIL THE ACTIVATION OF G1 CYCLINS IN THE NEXT CYCLE [J].
AMON, A ;
IRNIGER, S ;
NASMYTH, K .
CELL, 1994, 77 (07) :1037-1050
[2]   DNA-SEQUENCE ANALYSIS OF 66 KB OF THE HUMAN MHC CLASS-II REGION ENCODING A CLUSTER OF GENES FOR ANTIGEN PROCESSING [J].
BECK, S ;
KELLY, A ;
RADLEY, E ;
KHURSHID, F ;
ALDERTON, RP ;
TROWSDALE, J .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 228 (02) :433-441
[3]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[4]   PROTEASOME COMPONENTS WITH RECIPROCAL EXPRESSION TO THAT OF THE MHC-ENCODED LMP PROTEINS [J].
BELICH, MP ;
GLYNNE, RJ ;
SENGER, G ;
SHEER, D ;
TROWSDALE, J .
CURRENT BIOLOGY, 1994, 4 (09) :769-776
[5]  
Betticher DC, 1996, ANN ONCOL, V7, P223
[6]   The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase [J].
Brandeis, M ;
Hunt, T .
EMBO JOURNAL, 1996, 15 (19) :5280-5289
[7]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[8]   The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells [J].
Cerundolo, V ;
Benham, A ;
Braud, V ;
Mukherjee, S ;
Gould, K ;
Macino, B ;
Neefjes, J ;
Townsend, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) :336-341
[9]   ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY [J].
CHOWDARY, DR ;
DERMODY, JJ ;
JHA, KK ;
OZER, HL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1997-2003
[10]  
CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582